A Comparison of Sanger Sequencing and Amplicon-Based Next Generation Sequencing Approaches for the Detection of HIV-1 Drug Resistance Mutations
Camilla Biba(University of Siena), Francesco Saladini(University of Siena)
Cited by 4
Related Papers
Agreement between an in‐house replication competent and a reference replication defective recombinant virus assay for measuring phenotypic resistance to <scp>HIV</scp>‐1 protease, reverse transcriptase, and integrase inhibitors
|Journal of Clinical Laboratory Analysis|2017|26
Polypharmacy, anticholinergic burden and drug–drug interaction assessment in people with four-class-resistant HIV: data from the PRESTIGIO registry
|Journal of Antimicrobial Chemotherapy|2024|7
Residual phenotypic susceptibility to doravirine in multidrug-resistant HIV-1 from subjects enrolled in the PRESTIGIO Registry
|International Journal of Antimicrobial Agents|2023|6
Use of next-generation sequencing on HIV-1 DNA to assess archived resistance in highly treatment-experienced people with multidrug-resistant HIV under virological control: data from the PRESTIGIO Registry
|Journal of Antimicrobial Chemotherapy|2024|6
Two-fold increased risk of cardiovascular events in people with MDR HIV: a matched cohort analysis with data from the PRESTIGIO registry
|Journal of Antimicrobial Chemotherapy|2024|2